SNPS vs TXG · P/E 63, rev $7.16B vs rev $301.9M
Synopsys Inc (SNPS) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported TXG revenue for 2026-06-30 was $301.9M. Net income was -$31.4M. TXG currently screens at market cap $4.08B.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. TXG currently screens at market cap $4.08B.
Not investment advice. Open the SNPS and TXG stock pages for the full models.
Not investment advice.